Bioorganic & Medicinal Chemistry · 2019 · 17 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsGlioblastomaOncology PharmacologyChemical Structure-activity RelationshipsLead Compound ScreeningPi3k InhibitorsPi3k-akt Signaling PathwayTargeted Kinase Inhibition
The search for novel targeted inhibitors active on glioblastoma multiforme is crucial to develop new treatments for this unmet clinical need. Herein, we report the results from a screening campaign against glioma cell lines using a proprietary library of 100 structurally-related pyrazolopyrimidines. Data analysis identified a family of compounds featuring a 2-amino-1,3-benzoxazole moiety (eCF309 to eCF334) for their antiproliferative properties in the nM range. These results were validated in patient-derived glioma cells. Available kinase inhibition profile pointed to blockade of the PI3K/mTOR pathway as being responsible for the potent activity of the hits. Combination studies demonstrated synergistic activity by inhibiting both PI3Ks and mTOR with selective inhibitors. Based on the structure activity relationships identified in this study, five new derivatives were synthesized and tested, which exhibited potent activity against glioma cells but not superior to the dual PI3K/mTOR inhibitor and lead compound of the screening eCF324.
15
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations
CellProfiler 3.0: Next-generation image processing for biology
Claire McQuin, Allen Goodman, Vasiliy S. Chernyshev et al. · PLoS Biology · 2018 · 2.1K citations · Full text
Adrian Folkes, Khatereh Ahmadi, W. Alderton et al. · Journal of Medicinal Chemistry · 2008 · 746 citations · Full text
SynergyFinder: a web application for analyzing drug combination dose–response matrix data
Aleksandr Ianevski, Liye He, Tero Aittokallio et al. · Bioinformatics · 2017 · 569 citations · Full text